by Linda Carey | Jan 20, 2018 | Breast Cancer News & Research, News, Uncategorized
Having lived with metastatic breast cancer for eleven years there are certain things that I take for granted. One is that everyone knows the definition of “metastatic.” I’m not sure what this says about me –perhaps I’ve been living in the crazy world of breast cancer... 
by The Tutu Team | Apr 3, 2017 | Uncategorized
Author: Shobhit Seth / Source: Investopedia U.S. pharmaceutical giant Pfizer Inc. (PFE ) announced that it has secured approval from the U.S. Food And Drug Administration (FDA) for a supplemental New Drug Application (sNDA) for its first-in-class cyclin... 
by The Tutu Team | Mar 14, 2017 | Uncategorized
Source: Reuters Novartis on Monday won U.S. Food and Drug Administration approval for Kisqali to treat postmenopausal women with a difficult-to-treat form of breast cancer, challenging Pfizer’s fast-growing Ibrance. The approval for Kisqali, previously known as... 
by The Tutu Team | Mar 14, 2017 | Uncategorized
Author: Linda A. Johnson / Source: CTVNews The logo of Swiss pharmaceutical company Novartis is seen at the Novartis Korea office in Seoul, South Korea on Saturday, Aug. 13, 2016. (AP / Ahn Young-joon) TRENTON, N.J. – U.S. regulators have approved a... by The Tutu Team | Oct 19, 2016 | Breast Cancer News & Research
October is Breast Cancer Awareness month and in honor of that, we are highlighting some of the latest breakthroughs in the cancer research all thanks to the many donations made throughout the world. Breast cancer is important because it affects so many and scientists... 